Literature DB >> 27462603

A female adnexal tumor of probable Wolffian origin showing positive O-6-methylguanine-DNA methyltransferase methylation.

Min Jung Kwon1, Min Jeong Yun1, Min Kyu Kim2.   

Abstract

Female adnexal tumor of probable Wolffian origin (FATWO) is a rare disease entity that arises from the mesonephric duct system. FATWO is different than other gynecological cancers in terms of embryology. Here, we describe the case of a 52-year-old woman with malignant FATWO. The patient underwent explorative laparotomy and surgical staging after a frozen section revealed malignancy. Detailed examination of the pathologic findings were consistent with FATWO. Counseling and further testing were provided to the patient to assess the risk of germline mutation and epigenetic change. An O-6-methylguanine-DNA methyltransferase gene methylation test was positive, and all other tests were normal. This is the first study to report a case of O-6-methylguanine-DNA methyltransferase methylation with FATWO in Korea.

Entities:  

Keywords:  Epigenesis, Genetic; O(6)-methylguanine-DNA methyltransferase methylation; Wolffian tumor

Year:  2016        PMID: 27462603      PMCID: PMC4958682          DOI: 10.5468/ogs.2016.59.4.328

Source DB:  PubMed          Journal:  Obstet Gynecol Sci        ISSN: 2287-8572


  14 in total

Review 1.  Epigenetics: regulation through repression.

Authors:  A P Wolffe; M A Matzke
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

2.  Methylation of discrete regions of the O6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene.

Authors:  G S Watts; R O Pieper; J F Costello; Y M Peng; W S Dalton; B W Futscher
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

Review 3.  Second case of uterine mesonephric adenocarcinoma.

Authors:  A Marquette; P Moerman; I Vergote; F Amant
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

Review 4.  Epigenetic impact of dietary isothiocyanates in cancer chemoprevention.

Authors:  Clarissa Gerhauser
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2013-07       Impact factor: 4.294

Review 5.  Normal and abnormal epithelial differentiation in the female reproductive tract.

Authors:  Takeshi Kurita
Journal:  Differentiation       Date:  2011-05-25       Impact factor: 3.880

6.  Female adnexal tumor of probable Wolffian origin. A distinctive pathologic entity.

Authors:  M H Kariminejad; R E Scully
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

Review 7.  Targeted modulation of MGMT: clinical implications.

Authors:  Lili Liu; Stanton L Gerson
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

Review 8.  Is female adnexal tumour of probable wolffian origin a benign lesion? A systematic review of the English literature.

Authors:  Mark K Heatley
Journal:  Pathology       Date:  2009       Impact factor: 5.306

Review 9.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

10.  A case of metastatic female adnexal tumor of probable Wolffian origin.

Authors:  Ryota Deshimaru; Tomoko Fukunaga; Teiko Sato; Shojiroh Morinaga; Mineo Takahashi
Journal:  Gynecol Oncol Rep       Date:  2014-10-01
View more
  2 in total

1.  Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases.

Authors:  Jennifer A Bennett; Lauren L Ritterhouse; Larissa V Furtado; Ricardo R Lastra; Anna Pesci; Jordan M Newell; Eike Burandt; Loes Kooreman; Koen Van de Vijver; Thomas Krausz; Ana Felix; Gian Franco Zannoni; Robert H Young; Esther Oliva
Journal:  Mod Pathol       Date:  2019-10-07       Impact factor: 7.842

Review 2.  Recurrent and metastatic female adnexal tumor of probable Wolffian origin: A case report and review of the literature.

Authors:  Qiuhe Chen; Yangmei Shen; Chuan Xie
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.